Our policy in the Medical Programs Department of the National Psoriasis Foundation (NPF) is to ensure balance, independence, objectivity, and scientific rigor in all our educational programs.  Anyone presenting or participating in the planning of any NPF CME programs is expected to disclose to the Medical Programs Department any real or apparent affiliation(s) within the past 12 months that may have a direct bearing on the subject matter of the continuing medical education program.  The intent of this policy is to ensure continuing medical education programs that are free of commercial interests.

The following faculty and planning committee have disclosed the following relationships with commercial interests:

Mark Lebwohl, MD, has disclosed the following conflicts of interest:

Research Funding: Abbvie, Boehringer Ingelheim, Celegene, Eli Lilly, Incyte, Janssen/Johnson & Johnson, Leo Pharmaceuticals, Medimmune/Astra Zeneca, Novartis, Pfizer, Sciderm, Valeant and ViDac

Consultant: Allergan, Aqua, Boehringer Ingelheim, LEO Pharma, Menlo, Mitsubishi, Promius and Theravance.

Planning Committee: Andi Agnew has disclosed no relevant financial interests with any commercial interests.